Form 8-K - Current report:
SEC Accession No. 0001193125-24-031008
Filing Date
2024-02-12
Accepted
2024-02-12 07:01:31
Documents
14
Period of Report
2024-02-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d744326d8k.htm   iXBRL 8-K 29963
  Complete submission text file 0001193125-24-031008.txt   158074

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA antx-20240212.xsd EX-101.SCH 2875
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE antx-20240212_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antx-20240212_pre.xml EX-101.PRE 11724
15 EXTRACTED XBRL INSTANCE DOCUMENT d744326d8k_htm.xml XML 3769
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41331 | Film No.: 24617335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)